Why the study?
Does an enhanced ACC/AHA guideline and practice-based risk factor strategy prevent sudden cardiac death in high-risk patients with hypertrophic cardiomyopathy?
Does an enhanced ACC/AHA guideline and practice-based risk factor strategy prevent sudden cardiac death in high-risk patients with hypertrophic cardiomyopathy?
An enhanced ACC/AHA risk factor strategy effectively predicts SCD events and guides prophylactic ICD implantation to prevent catastrophic arrhythmias in high-risk HCM patients.
Answers are grounded in this paper and cite their sources.
Supports enhanced SCD risk stratification in HCM; hypothesis-generating for ICD decisions pending randomized confirmation.
A systematic enhanced ACC/AHA guideline and practice-based risk factor strategy prospectively predicted SCD events in nearly all at-risk patients with HCM, resulting in prophylactically implanted ICDs that prevented many catastrophic arrhythmic events in this at-risk population.
No takes yet. Share an insight, caveat, or question.
Maron et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: